This renewal application from the Medical University of South Carolina (MUSC) requests support for the continuation of the NIDA Mentored Clinical Scientists Development Program in Drug Abuse and Addiction (NIDA K12) at MUSC. Established in 2012, the overall objective of the NIDA K12 program was to establish an intensive program of mentored clinical research training and career development activities to promote Scholars' research independence in the area of drug abuse and addiction. The substantial expertise in addictions research at MUSC ensures our ability to mentor individuals in early stages of their research careers to contribute significantly to the understanding and treatment of substance use disorders. In the initial funding period, infrastructure of a strong mentorship development program was established, and participating Scholars have had significant success in obtaining independent federal funding. This application requests support to build on these early programmatic successes by making innovative changes to strengthen the K12 program. Specifically, we will focus on providing novel training opportunities and hands-on experience to promote addiction team science among our K12 Scholars, as well as increase opportunities for training in areas such as mHealth, biomedical imaging, public health, and biomedical informatics. Additionally, in keeping with the mission of NIDA, emphasis during the renewal funding period will continue to be placed on attracting and training clinical researchers to ensure that a diverse pool of highly trained scientists will be available to address the Nation's critical health care needs in the area of drug abuse. The renewal of the NIDA K12 program would allow us to continue to meet the urgent need to extend the addictions research training potential to faculty-level trainees at MUSC, and to continue our synergistic work with existing programs on campus to attract and promote faculty development in clinical research focused on addictions throughout the educational continuum.

Public Health Relevance

The participation of clinician-scientists in the biomedical research enterprise helps bridge the gap between basic science and clinical practice. Intensive, mentored clinical training focused on drug abuse and addiction helps ensure that there is a diverse pool of highly trained clinician-scientists available to address the Nation's critical health care needs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
2K12DA031794-06A1
Application #
9505508
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Lao, Guifang
Project Start
2013-01-15
Project End
2023-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Psychiatry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Nguyen-Louie, Tam T; Courtney, Kelly E; Squeglia, Lindsay M et al. (2018) Prospective changes in neural alcohol cue reactivity in at-risk adolescents. Brain Imaging Behav 12:931-941
Heckman, Bryan W; Dahne, Jennifer; Germeroth, Lisa J et al. (2018) Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers. J Consult Clin Psychol 86:903-914
Baker, Nathaniel L; Gray, Kevin M; Sherman, Brian J et al. (2018) Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. Drug Alcohol Depend 187:270-277
McClure, Erin A; Tomko, Rachel L; Carpenter, Matthew J et al. (2018) Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse 44:561-570
Jacobus, Joanna; Taylor, Charles T; Gray, Kevin M et al. (2018) A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users. Drug Alcohol Depend 187:195-204
Tomko, Rachel L; Baker, Nathaniel L; McClure, Erin A et al. (2018) Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend 182:1-7
Tomko, Rachel L; Gray, Kevin M; Oppenheimer, Stephanie R et al. (2018) Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. Am J Drug Alcohol Abuse :1-16
Sherman, Brian J; Baker, Nathaniel L; Squeglia, Lindsay M et al. (2018) Approach bias modification for cannabis use disorder: A proof-of-principle study. J Subst Abuse Treat 87:16-22
Squeglia, Lindsay M; Tomko, Rachel L; Baker, Nathaniel L et al. (2018) The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend 185:17-22
Tomko, Rachel L; Saladin, Michael E; Baker, Nathaniel L et al. (2018) Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res :

Showing the most recent 10 out of 81 publications